In addition, the survival rate of cells treated with TGF-β1+erastin was the lowest, which was significantly different from other control groups, suggesting that induction of ferroptosis may accelerate the death of HFL1 cells to aggravate IPF. The gene discussed is TGFB1; the disease is idiopathic pulmonary fibrosis.